InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
ExecutiveDisclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Discover the complete record of transactions filed by Ryll Thomas, Vice-Président Senior. Director active across 1 company, notably ImmunoGen, Inc.. Aggregated, 2 reports have been logged. History available since 30 June 2021. The latest transaction was filed on 30 June 2021 (Attribution). Regulator: SEC (Form 4). All data is accessible without signup.
Declarations2 total
3,849 shares@ US$5.5250.0% of flowCommon StockSEC:0001179110-21-007314
3,849 shares@ US$5.5250.0% of flowCommon StockSEC:0001179110-21-007314:0
2 of 2 declarations
About Ryll Thomas
Thomas Ryll is Senior Vice President of Technical Operations at ImmunoGen, Inc. He oversees the company's technical operations, contributing to innovation and product improvement. His role is crucial for ImmunoGen's success.
